Researchers at the University of California, Davis, led by Sara K. Pintwala and Patrick M. Fuller, used single-nucleus RNA sequencing to profile individual neurons from the lateral hypothalamus of adult female and male mice. The technique captures the complete transcriptome — the full inventory of genes being actively read — from thousands of individual cell nuclei at once. Tissue was collected precisely at the onset of the dark phase, zeitgeber time 12, a biologically charged moment when nocturnal animals transition from rest to activity and when competing drives like feeding, exploration, and wakefulness surge together.

The team sequenced more than 85,000 nuclei in total, ultimately isolating 33,235 high-quality neuronal nuclei — 16,432 from females and 16,803 from males. After correcting for ambient RNA contamination, removing doublets, and integrating the datasets to control for batch effects, the researchers asked a deceptively simple question: do male and female lateral hypothalamic neurons differ in the genes that build and receive circadian signals?

The first surprise was what they did not find. When the researchers clustered all the nuclei together using unsupervised computational methods, the analysis revealed 24 distinct neuronal clusters — and every single one contained cells from both sexes. There was no evidence of sex-specific neuron classes, and the relative proportions of major cell types were nearly identical between males and females. Glutamatergic, GABAergic, orexin-producing, and melanin-concentrating hormone-associated populations were all represented at matching ratios, with odds ratios hovering close to 1.0. Structurally, the male and female lateral hypothalamus looked like the same brain region.

But beneath that conserved architecture, the molecular machinery told a different story. The researchers focused on a curated panel of clock and circadian signaling genes: the core activators Clock, Arntl (which encodes BMAL1), and Npas2; the repressors Per1, Per2, Per3, Cry1, and Cry2; auxiliary regulators such as Nr1d1, Nr1d2, and the ROR family; and receptors for the suprachiasmatic nucleus’s signature neuropeptides, including vasoactive intestinal peptide (VIP), arginine vasopressin (AVP), gastrin-releasing peptide, neuromedin S, cholecystokinin, and melatonin. Differential expression testing, corrected for false discovery, uncovered 15 genes whose expression differed significantly between the sexes.

The pattern of those differences was strikingly coherent. Female-derived neurons were enriched for the vasopressin receptor Avpr1a, the melatonin receptor Mtnr1b, the clock repressors Per2 and Per3, and the auxiliary regulators Nr1d1, Nr1d2, and Rora. Male-derived neurons, by contrast, showed enrichment for the VIP receptor Vipr2, along with Nmur2 and Cckar — receptors for neuromedin and cholecystokinin signaling — and, notably, for the core positive-limb oscillator genes Clock, Npas2, and Arntl, plus Per1, Cry1, and Rorb. In other words, the two sexes appeared to weight different limbs of the same circadian feedback loop, and different neuromodulatory input channels, across shared neuronal populations.

These motifs repeated across cell types. In glutamatergic neurons, females preferentially expressed AVP and melatonin-related transcripts while males emphasized VIP and CCK receptors alongside Npas2 and Clock. In GABAergic neurons, female enrichment again centered on Nr1d2, Per2, Per3, Rora, and the melatonin receptor Mtnr1a, while males showed elevated Nmur2, Rorb, Vipr2, Per1, Cry1, Arntl, and Clock. Among the peptidergic populations, differences were subtler but still present: Npas2 was enriched in female orexin neurons, while male melanin-concentrating hormone neurons showed enrichment for Rora, Cry1, Arntl, Npas2, and Mtnr1a. The consistency across excitatory, inhibitory, and neuropeptide-specific populations suggests a coordinated, system-level shift in how temporal information is processed, rather than random noise.

The functional implications are considerable. AVP signaling from the suprachiasmatic nucleus is a principal conduit of circadian output, critical for synchrony and phase regulation, while VIP is essential for keeping pacemaker neurons firing in unison. Neuromedin S-producing neurons act as pacemakers that couple clock cells across the circadian network, and cholecystokinin pathways have been implicated in circadian adaptation under changing photoperiods. If female lateral hypothalamic neurons are transcriptionally primed to receive vasopressin-dominant signals while male neurons favor VIP, neuromedin, and CCK inputs, then the same upstream timing information from the master clock could be translated into different downstream behavioral and physiological outputs in each sex — different thresholds for arousal, feeding, stress responsiveness, and sleep-wake transitions at the same time of day.

The study also mapped sex hormone receptor expression across all lateral hypothalamic neuron types, finding that androgen receptor transcripts were most abundant, estrogen receptor 1 moderate, and estrogen receptor 2 lowest, in both sexes. Because estrogen receptor 1 functions as a ligand-activated transcription factor known to drive expression of Per2 and Clock in hypothalamic neurons, its widespread presence identifies a concrete molecular route through which circulating steroids could reshape circadian transcription in a sex-dependent manner. This aligns with earlier work showing that androgens alter the magnitude of light-induced phase shifts and that estrogen signaling stabilizes firing synchrony in the suprachiasmatic nucleus.

The authors are careful about what their data can and cannot show. Because tissue was sampled at a single circadian timepoint in gonad-intact animals without estrous-cycle staging, the findings cannot establish whether the observed differences reflect stable sex dimorphism, fluctuating endocrine state, circadian phase, or interactions among all three. Nor can a snapshot at dark-phase onset reveal oscillatory amplitude or phase relationships across the full 24-hour cycle. What the study does establish is a framework: sexual dimorphism in the lateral hypothalamus emerges not through fundamentally distinct neuronal populations but through subtle, reproducible, and coordinated shifts in molecular signaling architecture — a differential tuning of shared circuits. As circadian and sleep medicine increasingly confront sex differences in rhythm period, amplitude, and disease vulnerability, the message is clear: the same clock may tick in everyone, but males and females may hear it through different molecular ears.

Subject of Research: Sex differences in circadian clock gene and neuropeptide receptor expression in the lateral hypothalamus

Article Title: Sex-associated circadian signaling signatures in the lateral hypothalamus

Article References: Pintwala, S. K., & Fuller, P. M. (2026). Sex-associated circadian signaling signatures in the lateral hypothalamus. Frontiers in Sleep, 5, 1895831. https://doi.org/10.3389/frsle.2026.1895831

Image Credits: AI Generated

DOI: 10.3389/frsle.2026.1895831

Keywords: lateral hypothalamus, circadian rhythms, single-nucleus RNA sequencing, sex differences, suprachiasmatic nucleus, orexin neurons, melanin-concentrating hormone, vasoactive intestinal peptide, arginine vasopressin, clock genes, hypothalamus, sleep-wake regulation

TaVNS is a non-invasive form of vagus nerve stimulation. Instead of an implanted electrode, it delivers gentle electrical pulses through the skin of the outer ear, specifically targeting the auricular branch of the vagus nerve, the only peripheral branch of this cranial nerve that reaches the body surface. From there, sensory signals travel to the nucleus tractus solitarius in the brainstem and cascade through autonomic and neuromodulatory systems, including the locus coeruleus and other arousal-related nuclei. Because the vagus nerve is a major conduit of the parasympathetic, rest-and-digest branch of the autonomic nervous system, researchers have long hypothesized that stimulating it could shift the body’s balance away from hyperarousal, the state of physiological vigilance that many insomnia researchers consider the core dysfunction of the disorder.

Most previous mechanistic studies of taVNS in insomnia have concentrated on the cortex and limbic system, examining regions such as the default mode network, the insula, and emotional regulation circuits. What has been missing, the authors argue, is attention to the hypothalamus, and in particular the lateral hypothalamus. This small, deep structure is not a passive relay; it is a master switch for arousal. It contains populations of neurons producing orexin, also known as hypocretin, the neuropeptide whose loss causes narcolepsy, as well as neurons producing melanin-concentrating hormone, which is involved in sleep regulation. The lateral hypothalamus also projects widely to cortical and subcortical networks that govern attention, reward, and autonomic tone. If taVNS genuinely works by modulating arousal systems, the lateral hypothalamus should sit at the center of the story, yet until now its role had barely been probed.

To fill that gap, the research team, led by Jingwen Zhang, Yue Zhang, Xiyong Dai, and colleagues at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, enrolled seventy patients with chronic insomnia and randomized them to receive either real or sham taVNS. The trial was registered with the Chinese Clinical Trial Registry in April 2019 and approved by the institution’s ethics committee, and all participants gave written informed consent. Before and after the treatment period, patients underwent resting-state functional MRI scans and completed standardized clinical instruments: the Pittsburgh Sleep Quality Index, the Insomnia Severity Index, and the Self-Rating Anxiety Scale. Using the bilateral lateral hypothalamus as seed regions, the investigators computed whole-brain functional connectivity, a measure of how synchronously activity in different brain regions fluctuates over time, and compared how these connectivity patterns changed between the real and sham stimulation groups.

The clinical results were clear. Compared with sham stimulation, real taVNS produced significantly greater reductions in PSQI, ISI, and anxiety scores, indicating improvements in sleep quality, insomnia severity, and anxiety symptoms. But the neuroimaging findings are what give the study its mechanistic teeth. Real stimulation strengthened functional connectivity between the left lateral hypothalamus and two regions: the right cerebellar Crus2 and the right precuneus. At the same time, it weakened connectivity between the left lateral hypothalamus and the left insula and the left orbital frontal cortex. Each of these changes is interpretable in the context of sleep and arousal neuroscience, and together they sketch a coherent picture of how peripheral nerve stimulation might reach deep into the brain’s arousal machinery.

Consider the strengthened connections first. The precuneus is a hub of the default mode network, the set of regions most active during rest and internally directed thought, and it is intimately involved in the transition between wakefulness and sleep. Cerebellar Crus2, meanwhile, has been repeatedly implicated in sleep-disordered networks and in the regulation of autonomic function. The finding that increased connectivity between the left lateral hypothalamus and Crus2 correlated with the degree of clinical improvement, with a correlation coefficient of -0.473 and a p-value of 0.011, is particularly striking, because it links a specific circuit change to a specific symptom outcome: the more this connection strengthened, the more patients’ sleep quality scores improved. The weakened connections tell a complementary story. The insula is central to interoception, the brain’s monitoring of internal bodily states, and hyperactive insula connectivity is often interpreted as a neural signature of heightened bodily awareness and arousal in insomnia. The orbital frontal cortex participates in valuation and emotional regulation. Reducing lateral hypothalamic coupling with these regions may reflect a dialing down of the vigilance and emotional reactivity that keep insomnia sufferers lying awake.

Beyond the group-level findings, the study ventured into more speculative but potentially transformative territory: predicting treatment response before it happens. The researchers built a whole-brain, voxel-wise support vector regression model, a machine learning approach that maps patterns of brain connectivity onto a continuous outcome, in this case the change in PSQI score within the real taVNS group. To keep the model honest, they used ReliefF feature selection to identify the most informative connectivity features, trained on seventy percent of the data and tested on the remaining thirty percent, and evaluated significance with 5,000 permutation tests. The single most predictive baseline feature involved the gyrus rectus, a medial prefrontal region adjacent to the orbital surface that is connected to limbic and autonomic circuits. The model achieved a correlation of 0.662 between predicted and observed improvement in the test set, with a p-value of 0.0264 and a permutation-corrected p-value of 0.0142.

That result, if it holds up, points toward a future in which a brief pretreatment brain scan could tell clinicians which insomnia patients are likely to respond to taVNS, sparing others the time and expense of an ineffective course. The authors are careful, however, to frame this as exploratory. The sample size was modest, the prediction analysis was conducted within the real stimulation group only, and the whole-brain machine learning approach carries well-known risks of overfitting even with permutation testing. The researchers explicitly state that these findings require validation in larger, independent cohorts and do not yet support clinical application. That caution is appropriate, and it is a welcome contrast to the hype that often surrounds brain stimulation and machine learning in popular coverage.

Nevertheless, the study’s significance is hard to overstate. It is among the first to demonstrate that a non-invasive, ear-based stimulation technique can measurably alter the functional connectivity of the lateral hypothalamus in humans, and that these alterations track with symptom improvement. It reframes taVNS not as a vague relaxation technique but as a targeted intervention on defined arousal circuitry, and it offers a candidate biomarker, lateral hypothalamic-cerebellar connectivity, for tracking treatment effects. For a disorder that is usually managed with medication or cognitive behavioral therapy, the prospect of a device-based, mechanistically grounded alternative is genuinely exciting.

Much work remains. Future studies will need larger and more diverse samples, longer follow-up periods to test whether the connectivity changes and clinical benefits persist, and designs that can disentangle taVNS effects from placebo responses more finely. Researchers will also want to determine optimal stimulation parameters, since frequency, intensity, and session duration all plausibly shape which circuits are engaged. But the core message of this trial stands on its own: the path to better sleep for chronic insomniacs may run through a small patch of skin on the ear, a wandering cranial nerve, and the ancient hypothalamic machinery that decides whether the brain stays awake or lets go into sleep.

Subject of Research: Effects of transcutaneous auricular vagus nerve stimulation on lateral hypothalamic functional connectivity in chronic insomnia

Article Title: Effects of transcutaneous auricular vagus nerve stimulation on lateral hypothalamic functional connectivity in chronic insomnia: a randomized, sham-controlled fMRI study with exploratory prediction of treatment response

Article References: Zhang, J., zhang, Y., Dai, X., Mai, R., Xu, B., & Liu, B. (2026). Effects of transcutaneous auricular vagus nerve stimulation on lateral hypothalamic functional connectivity in chronic insomnia: a randomized, sham-controlled fMRI study with exploratory prediction of treatment response. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08708-4

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08708-4

Keywords: chronic insomnia, taVNS, vagus nerve stimulation, lateral hypothalamus, functional connectivity, fMRI, sleep-wake regulation, machine learning, support vector regression, precuneus, cerebellum, treatment response prediction